Ellis CS - Search Results

1

Incidence of pulmonary toxicity in bleomycin-containing regimens for testicular cancer with and without the use of growth factor.

McAvoy C, Fields P, Otto D, Kreimer A, Ellis CS. McAvoy C, et al. Among authors: ellis cs. J Oncol Pharm Pract. 2024 Jan 30:10781552231225766. doi: 10.1177/10781552231225766. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 38291671

2

Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer.

Myint ZW, Kolesar JM, McCorkle JR, Wu J, Ellis CS, Otto DE, Wang P. Myint ZW, et al. Among authors: ellis cs. Med Sci Monit. 2022 Oct 14;28:e938091. doi: 10.12659/MSM.938091. Med Sci Monit. 2022. PMID: 36229939 Free PMC article.

3

A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer.

Myint ZW, St Clair WH, Strup SE, Yan D, Li N, Allison DB, McLouth LE, Ellis CS, Wang P, James AC, Hensley PJ, Otto DE, Arnold SM, DiPaola RS, Kolesar JM. Myint ZW, et al. Among authors: ellis cs. Cancers (Basel). 2023 Apr 27;15(9):2505. doi: 10.3390/cancers15092505. Cancers (Basel). 2023. PMID: 37173971 Free PMC article.

4

Implementation of a medication delivery service for ambulatory oncology infusion patients.

Butts AR, Ellis CS, Travers EA, Reynolds JW, Rogers LE, Otto DE, Schwieterman PA. Butts AR, et al. Among authors: ellis cs. J Oncol Pharm Pract. 2023 Jul 10:10781552231185527. doi: 10.1177/10781552231185527. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 37431207

5

A Case Report of Metastatic Castration-Resistant Prostate Cancer Harboring a PTEN Loss.

Myint ZW, Allison DB, Ellis CS. Myint ZW, et al. Among authors: ellis cs. Front Oncol. 2021 Sep 23;11:731002. doi: 10.3389/fonc.2021.731002. eCollection 2021. Front Oncol. 2021. PMID: 34631559 Free PMC article.

6

Case Report: Safety and Efficacy of Enfortumab Vedotin in a Patient With Metastatic Urothelial Carcinoma Undergoing Peritoneal Dialysis.

Collette KR, Myint ZW, Parasramka SV, Ellis CS. Collette KR, et al. Among authors: ellis cs. Front Oncol. 2022 May 25;12:892793. doi: 10.3389/fonc.2022.892793. eCollection 2022. Front Oncol. 2022. PMID: 35692805 Free PMC article.

7

Case report: Enfortumab vedotin induced refractory DKA and multi organ failure - a rare fatal adverse event.

Kapoor AK, Ellis CS, Pandey D, Allison DB, Myint ZW. Kapoor AK, et al. Among authors: ellis cs. Front Oncol. 2024 Feb 15;14:1332478. doi: 10.3389/fonc.2024.1332478. eCollection 2024. Front Oncol. 2024. PMID: 38425338 Free PMC article.

8

Minimizing opioid use after acute major trauma.

Oyler D, Bernard AC, VanHoose JD, Parli SE, Ellis CS, Li D, Procter LD, Chang PK. Oyler D, et al. Among authors: ellis cs. Am J Health Syst Pharm. 2018 Feb 1;75(3):105-110. doi: 10.2146/ajhp161021. Am J Health Syst Pharm. 2018. PMID: 29371190

9

Case-Based Clinical Guidance on Dosing and Management of the Hepatic Artery Infusion Chemotherapy Pump.

Rao D, Ellis CS, Kemeny N, Cercek A. Rao D, et al. Among authors: ellis cs. JCO Oncol Pract. 2024 Feb;20(2):187-194. doi: 10.1200/OP.23.00374. Epub 2023 Oct 26. JCO Oncol Pract. 2024. PMID: 37883732 Review.

10

A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease.

Choi M, Harper MM, Pandalai PK, Abdel-Misih SRZ, Patel RA, Ellis CS, Reusch E, Reynolds J, Vacchi-Suzzi C, Park JM, Georgakis GV, Kim J. Choi M, et al. Among authors: ellis cs. Ann Surg Oncol. 2023 Feb;30(2):804-813. doi: 10.1245/s10434-022-12723-6. Epub 2022 Nov 7. Ann Surg Oncol. 2023. PMID: 36344711 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page